Strategies to investigate and mitigate collider bias in genetic and Mendelian randomisation studies of disease progression
PLOS Genetics · 23.02.2023 · 19 (2) · e1010596
DOI: 10.1371/journal.pgen.1010596 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PLOS Genetics, online erschienen am 23.02.2023. Verfasst von Ruth E Mitchell und 9 weiteren Autor:innen. Beteiligte Einrichtung: MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Mendelian Randomization Analysis. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Jonathan and Georgina de Pass studentship.
Abstract (Originalsprache)
Genetic studies of disease progression can be used to identify factors that may influence survival or prognosis, which may differ from factors that influence on disease susceptibility. Studies of disease progression feed directly into therapeutics for disease, whereas studies of incidence inform prevention strategies. However, studies of disease progression are known to be affected by collider (also known as “index event”) bias since the disease progression phenotype can only be observed for individuals who have the disease. This applies equally to observational and genetic studies, including genome-wide association studies and Mendelian randomisation (MR) analyses. In this paper, our aim is to review several statistical methods that can be used to detect and adjust for index event bias in studies of disease progression, and how they apply to genetic and MR studies using both individual- and summary-level data. Methods to detect the presence of index event bias include the use of negative controls, a comparison of associations between risk factors for incidence in individuals with and without the disease, and an inspection of Miami plots. Methods to adjust for the bias include inverse probability weighting (with individual-level data), or Slope-Hunter and Dudbridge et al.’s index event bias adjustment (when only summary-level data are available). We also outline two approaches for sensitivity analysis. We then illustrate how three methods to minimise bias can be used in practice with two applied examples. Our first example investigates the effects of blood lipid traits on mortality from coronary heart disease, while our second example investigates genetic associations with breast cancer mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
- Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
ORCID-Profile: Ruth E Mitchell, Venexia M Walker, Apostolos Gkatzionis
Förderung
- Medical Research Council
- Jonathan and Georgina de Pass studentship
Zitieren
APA
Mitchell, R. E., Hartley, A. E., Walker, V. M., Gkatzionis, A., Yarmolinsky, J., Bell, J. A., Chong, A. H. W., Paternoster, L., Tilling, K., & Smith, G. D. (2023). Strategies to investigate and mitigate collider bias in genetic and Mendelian randomisation studies of disease progression. PLOS Genetics, 19(2), e1010596. https://doi.org/10.1371/journal.pgen.1010596
Vancouver
Mitchell RE, Hartley AE, Walker VM, Gkatzionis A, Yarmolinsky J, Bell JA, et al. Strategies to investigate and mitigate collider bias in genetic and Mendelian randomisation studies of disease progression. PLOS Genetics. 2023;19(2):e1010596. doi:10.1371/journal.pgen.1010596
BibTeX
@article{Mitchell2023,
author = {Mitchell, Ruth E and Hartley, April E and Walker, Venexia M and Gkatzionis, Apostolos and Yarmolinsky, James and Bell, Joshua A and Chong, Amanda H W and Paternoster, Lavinia and Tilling, Kate and Smith, George Davey},
title = {Strategies to investigate and mitigate collider bias in genetic and Mendelian randomisation studies of disease progression},
journal = {PLOS Genetics},
year = {2023},
volume = {19},
number = {2},
pages = {e1010596},
doi = {10.1371/journal.pgen.1010596}
}
EUVIMED